Astria Therapeutics, Inc.

Ownership Transactions Reported by 16 Insiders

Symbol
ATXS on Nasdaq
Location
22 Boston Wharf Road, 10 Th Floor, Boston, MA

There are no Buy or Sell transactions made by insiders since 10/8/2024

Astria Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Perceptive Advisors Llc Director $67.2M Feb 1, 2024
Christopher Morabito Chief Medical Officer $0 Mar 21, 2025
Michael Kishbauch Director Jun 11, 2025
Kenneth Bate Director Jun 11, 2025
Joanne Beck Director Jun 11, 2025
Andrew John Nichols Chief Scientific Officer Mar 1, 2022
Andrew Komjathy Chief Commercial Officer Mar 21, 2025
Andrea Matthews Chief Business Officer Mar 21, 2025
Jill C. Milne CEO and President, Director Mar 21, 2025
Hugh Cole Director Jun 11, 2025
Fred Callori Director Jun 11, 2025
Jonathan Violin Director Jun 11, 2025
Noah Clauser Chief Financial Officer Mar 21, 2025
Sunil Agarwal Director Jun 11, 2025
Benjamin Harshbarger Chief Legal Officer Mar 21, 2025
Anthony Gregg Lapointe Director Jun 11, 2025

Recent Insider Transactions by Companies or Individuals for Astria Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.